Interim analysis of a prospective, randomized phase II trial of trastuzumab vs trastuzumab + E75
Presented by Tommy A Brown at the MS03: Full-Day Military Surgical Symposium – General Surgery Presentations during the SAGES 2018 Annual Meeting.
Final report of a randomized phase 1b trial to assess sequencing of the E39 & E39′ vaccines
Presented by John W Myers at the MS01: Full-Day Military Surgical Symposium – Basic Science Presentations during the SAGES 2018 Annual Meeting.